Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products.

[1]  S. Lovestone.  Early diagnosis and the clinical genetics of Alzheimer’s disease , 1999, Journal of Neurology.

[2]  L. Marnett,et al.  Free radical epoxidation of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by hematin and polyunsaturated fatty acid hydroperoxides , 1981 .

[3]  J L Witztum,et al.  Oxidized phospholipids and isoprostanes in atherosclerosis. , 1998, Current opinion in lipidology.

[4]  S. Wright,et al.  Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. , 2004, DNA and cell biology.

[5]  Guoyao Wu,et al.  Linoleic acid-induced endothelial activation: role of calcium and peroxynitrite signaling. , 2004, Journal of lipid research.

[6]  L. Marnett.  Oxy radicals, lipid peroxidation and DNA damage. , 2002, Toxicology.

[7]  E. Stadtman,et al.  Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. , 1989, The Journal of biological chemistry.

[8]  T. Osawa,et al.  Covalent attachment of 4-hydroxy-2-nonenal to erythrocyte proteins. , 1997, Journal of biochemistry.

[9]  P. Stenvinkel,et al.  Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  G. Spiteller.  Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases. , 1998, Chemistry and physics of lipids.

[11]  Stanley L. Hazen,et al.  Identification of &agr;-Chloro Fatty Aldehydes and Unsaturated Lysophosphatidylcholine Molecular Species in Human Atherosclerotic Lesions , 2003 .

[12]  W. Jira,et al.  Increase in hydroxy fatty acids in human low density lipoproteins with age. , 1996, Chemistry and physics of lipids.

[13]  R. G. Salomon,et al.  Oxidized phospholipids, isolevuglandins, and atherosclerosis. , 2005, Molecular nutrition & food research.

[14]  G. Spiteller,et al.  Oxidized phytosterols increase by ageing in photoautotrophic cell cultures of Chenopodium rubrum , 1997 .

[15]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[16]  G. Spiteller,et al.  Epoxidierung von Kohlenstoff-Kohlenstoff-Doppelbindungen in Terpenen durch Linolsäurehydroperoxide , 1993 .

[17]  N. Bogdanovic,et al.  The Swedish APP670/671 Alzheimer’s Disease Mutation: The First Evidence for Strikingly Increased Oxidative Injury in the Temporal Inferior Cortex , 2001, Dementia and Geriatric Cognitive Disorders.

[18]  Spiteller.  Identification of Toxic 2,4-Decadienal in Oxidized, Low-Density Lipoprotein by Solid-Phase Microextraction. , 2000, Angewandte Chemie.

[19]  U. Walther,et al.  Zur Bildung von Ölsäureepoxid bei der Lagerung technischer Ölsäure , 1993 .

[20]  D. Collen,et al.  Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. , 1998, Atherosclerosis.

[21]  Catherine M Smart,et al.  Gene expression during leaf senescence. , 1994, The New phytologist.

[22]  A. C. Nicholson,et al.  Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[23]  D. Alkon,et al.  Oxidation of Cholesterol by Amyloid Precursor Protein and β-Amyloid Peptide* , 2005, Journal of Biological Chemistry.

[24]  B. Hyman,et al.  Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.

[25]  R. Clark,et al.  Oxidation of lysine side-chains of elastin by the myeloperoxidase system and by stimulated human neutrophils. , 1986, Biochemical and biophysical research communications.

[26]  R. Schmidt,et al.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. , 1997, The American journal of pathology.

[27]  D. Steinberg,et al.  Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors. , 2000, Journal of lipid research.

[28]  S. Lipton,et al.  Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Massel,et al.  Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteries. , 1999, The Canadian journal of cardiology.

[30]  W. Kern,et al.  Synthesis and Properties of Naturally Occurring α- Hydroxyaldehydes. , 1996 .

[31]  V. Monnier,et al.  Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo. , 1989, The Journal of biological chemistry.

[32]  D. Steinberg.  Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. , 2005, Molecular nutrition & food research.

[33]  G. Spiteller.  Furan fatty acids: Occurrence, synthesis, and reactions. Are furan fatty acids responsible for the cardioprotective effects of a fish diet? , 2005, Lipids.

[34]  S. Genuth,et al.  Glycation Products as Markers and Predictors of the Progression of Diabetic Complications , 2005, Annals of the New York Academy of Sciences.

[35]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Brunke,et al.  The essential oil of Rhus coriaria L. fruits , 1993 .

[37]  G. Besser,et al.  Met-enkephalin circulates in human plasma , 1980, Nature.

[38]  M. V. van Eden,et al.  Deleterious iron-mediated oxidation of biomolecules. , 2002, Free radical biology & medicine.

[39]  W. Markesbery,et al.  Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures , 2001, Neurobiology of Aging.

[40]  D. Steinberg,et al.  The oxidative modification hypothesis of atherosclerosis: does it hold for humans? , 2001, Trends in cardiovascular medicine.

[41]  M. Carson,et al.  The Push-Me Pull-You of T Cell Activation , 2001, Science.

[42]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[43]  E. Araki,et al.  Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway* , 2005, Journal of Biological Chemistry.

[44]  G. Spiteller,et al.  Detection of short-chain alpha-hydroxyaldehydic compounds as pentafluorbenzyloxime derivatives in bovine liver. , 1995, Chemistry and physics of lipids.

[45]  D. Butterfield,et al.  The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. , 2005, Biochimica et biophysica acta.

[46]  B. Staels,et al.  Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall , 2001, Zeitschrift für Kardiologie.

[47]  W. Powell,et al.  Increased levels of monohydroxy metabolites of arachidonic acid and linoleic acid in LDL and aorta from atherosclerotic rabbits. , 1991, Biochimica et biophysica acta.

[48]  Mark P Mattson,et al.  Neuronal and glial calcium signaling in Alzheimer's disease. , 2003, Cell calcium.

[49]  C. Napoli,et al.  Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis , 2005, Neurobiology of Aging.

[50]  J. Vliegenthart,et al.  Demonstration by EPR spectroscopy of the functional role of iron in soybean lipoxygenase-1. , 1975, Biochimica et biophysica acta.

[51]  R. Griffiths,et al.  Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse , 1997, Psychopharmacology.

[52]  H. Shen,et al.  Aflatoxin B1-induced lipid peroxidation in rat liver. , 1994, Toxicology and applied pharmacology.

[53]  B. Ohlsson,et al.  Oxysterols induce interleukin‐1β production in human macrophages , 2002, European journal of clinical investigation.

[54]  G. Spiteller,et al.  Transformations of 12,13-Epoxy-ll-hydroxy-9-octadecenoic Acid and 4,5-Epoxy-N-acetylsphingosine by Incubation with Liver Homogenate and Liver Microsomes , 2000, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[55]  R. Bryant,et al.  Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats. , 1980, Biochemical and biophysical research communications.

[56]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[57]  F. Mach,et al.  Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[58]  C. Glass,et al.  Differential recruitment of the coactivator proteins CREB-binding protein and steroid receptor coactivator-1 to peroxisome proliferator-activated receptor gamma/9-cis-retinoic acid receptor heterodimers by ligands present in oxidized low-density lipoprotein. , 2003, The Journal of endocrinology.

[59]  Jeffrey K. Yao,et al.  Oxidative Damage and Schizophrenia , 2001, CNS drugs.

[60]  P. Jenner.  Oxidative damage in neurodegenerative disease , 1994, The Lancet.

[61]  T. Montine,et al.  E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.

[62]  W. Garvey,et al.  The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. , 2002, Atherosclerosis.

[63]  N. Leitinger.  Oxidized phospholipids as modulators of inflammation in atherosclerosis , 2003, Current opinion in lipidology.

[64]  V. Monnier,et al.  Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.

[65]  K. Uchida,et al.  Oxidative fragmentation of collagen and prolyl peptide by Cu(II)/H2O2. Conversion of proline residue to 2-pyrrolidone. , 1992, The Journal of biological chemistry.

[66]  E. Oliw,et al.  Oxygenation of Arachidonic Acid by Cytochromes P‐450 , 1999 .

[67]  T. Pedersen,et al.  Hyperlipidaemia and aortic valve disease , 2004, Current opinion in lipidology.

[68]  G. Spiteller,et al.  Increase of Caryophyllene Oxide in Ageing Lemon Balm Leaves (Melissa officinalis L.) -A Consequence of Lipid Peroxidation? , 1996 .

[69]  S. Hazen,et al.  Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. , 2000, Biochimica et biophysica acta.

[70]  B. Halliwell,et al.  Oxygen radicals and the nervous system , 1985, Trends in Neurosciences.

[71]  J. Cazenave,et al.  Platelet phospholipids are differentially protected against oxidative degradation by plasmalogens , 2002, Lipids.

[72]  M. Cybulsky,et al.  NF-κB: pivotal mediator or innocent bystander in atherogenesis? , 2001 .

[73]  C. Akoh,et al.  Methods for measuring oxidative rancidity in fats and oils. , 2002 .

[74]  S. Younkin,et al.  Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse , 2003 .

[75]  J. Ngeh,et al.  Inflammation, infection and antimicrobial therapy in coronary heart disease – where do we currently stand? , 2001, Fundamental & clinical pharmacology.

[76]  K. Honn,et al.  Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5 , 2012, Advances in Experimental Medicine and Biology.

[77]  I. Sergiev,et al.  The effect of drought and ultraviolet radiation on growth and stress markers in pea and wheat , 2001 .

[78]  B Chance,et al.  The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. , 1973, The Biochemical journal.

[79]  J. Vliegenthart,et al.  Spectroscopic studies on the active site of hydroperoxide lyase; the influence of detergents on its conformation , 2001, FEBS letters.

[80]  I. Björkhem,et al.  On the mechanism of oxidation of cholesterol at C-7 in a lipoxygenase system. , 1992, The Journal of biological chemistry.

[81]  A. Lupo,et al.  Evaluation of Glyoxal and Methylglyoxal Levels in Uremic Patients under Peritoneal Dialysis , 2005, Annals of the New York Academy of Sciences.

[82]  E. Niki,et al.  Acrolein Is a Product of Lipid Peroxidation Reaction , 1998, The Journal of Biological Chemistry.

[83]  K. Wang.  Caspases: a drug discovery perspective. , 1999, Current opinion in drug discovery & development.

[84]  R. Brigelius-Flohé.  Tissue-specific functions of individual glutathione peroxidases. , 1999, Free radical biology & medicine.

[85]  G. Stewart,et al.  Leukotoxins of gram-negative bacteria. , 2002, Veterinary microbiology.

[86]  G. Spiteller.  Is Atherosclerosis a Multifactorial Disease or Is It Induced by a Sequence of Lipid Peroxidation Reactions? , 2005, Annals of the New York Academy of Sciences.

[87]  M. Reilly,et al.  Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Seon-Hwa Lee,et al.  Oxidative DNA damage and cardiovascular disease. , 2001, Trends in cardiovascular medicine.

[89]  T. Montine,et al.  Lipid peroxidation in aging brain and Alzheimer's disease. , 2002, Free radical biology & medicine.

[90]  E. Schiffrin,et al.  Beyond blood pressure: the endothelium and atherosclerosis progression. , 2002, American journal of hypertension.

[91]  L. Horrocks,et al.  Plasmalogens, docosahexaenoic acid and neurological disorders. , 2003, Advances in experimental medicine and biology.

[92]  R. Pontcharraud,et al.  Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates. , 2004, Chemistry and physics of lipids.

[93]  Andreas Hald,et al.  Oxidative stress and inflammation in Parkinson's disease: is there a causal link? , 2005, Experimental Neurology.

[94]  J. Hathcock.  Evaluation of fao/who pesticide standards in relation to polish and honduran diets , 1983 .

[95]  K. Uchida,et al.  Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. , 1994, The Journal of biological chemistry.

[96]  P Kouklis,et al.  Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. , 2001, The Journal of physiology.

[97]  J. Pettegrew,et al.  Brain Membrane Phospholipid Alterations in Alzheimer's Disease , 2001, Neurochemical Research.

[98]  I. Buttino,et al.  Bioactive aldehydes from diatoms block the fertilization current in ascidian oocytes , 2003, Molecular reproduction and development.

[99]  H. Kuhn,et al.  Sequence determinants for the positional specificity of lipoxygenases. , 2002, Advances in experimental medicine and biology.

[100]  O. Witte,et al.  Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A , 2001, Science.

[101]  T. Osawa,et al.  Glucosone as a Radical-Generating Intermediate in the Advanced Maillard Reaction , 1996 .

[102]  F. Crews.  Alcohol and Neurodegeneration , 2006 .

[103]  I. Puddey,et al.  Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. , 2003, Atherosclerosis.

[104]  H. Sies.  Biochemie des oxidativen Stress , 1986 .

[105]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[106]  A. Favier,et al.  Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? , 2002, Journal of Neurology.

[107]  P. Domingues,et al.  Identification of oxidation products and free radicals of tryptophan by mass spectrometry , 2003, Journal of the American Society for Mass Spectrometry.

[108]  D. Butterfield,et al.  Free radicals and brain aging. , 2004, Clinics in geriatric medicine.

[109]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[110]  C. Sonntag.  Free-Radical Reactions of Carbohydrates as Studied by Radiation Techniques , 1980 .

[111]  S. Toyokuni,et al.  Endogenous Formation of Protein Adducts with Carcinogenic Aldehydes , 2001, The Journal of Biological Chemistry.

[112]  Paul J Thornalley,et al.  The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. , 1984 .

[113]  H. Hartung,et al.  Statins — a cure-all for the brain? , 2005, Nature Reviews Neuroscience.

[114]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[115]  D. Steinberg,et al.  The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.

[116]  B. Zilinskas,et al.  Salt and oxidative stress: similar and specific responses and their relation to salt tolerance in Citrus , 1997, Planta.

[117]  G. Spiteller,et al.  9-Hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE): excellent markers for lipid peroxidation , 1997 .

[118]  G. Spiteller,et al.  Oxidation of D-(-)-Ribose with H2O2 and Lipid Hydroperoxides , 1996 .

[119]  G. Spiteller,et al.  Iron Release from the Active Site of Lipoxygenase , 2000 .

[120]  G. Poli,et al.  4‐Hydroxynonenal in the Pathomechanisms of Oxidative Stress , 2000, IUBMB life.

[121]  J. Trojanowski,et al.  Increased 8,12‐iso‐iPF2α‐VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity , 2000, Annals of neurology.

[122]  G. Sobue,et al.  Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease , 2002, Acta Neuropathologica.

[123]  F. McArdle,et al.  Intracellular generation of reactive oxygen species by contracting skeletal muscle cells. , 2005, Free radical biology & medicine.

[124]  T. Montine,et al.  Carbonyl toxicology and Alzheimer's disease. , 2002, Toxicology and applied pharmacology.

[125]  W. Vogt.  Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.

[126]  Alexander D. MacKerell,et al.  Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. , 2002, Journal of the American Chemical Society.

[127]  T. Montine,et al.  Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy. , 1998, Chemical research in toxicology.

[128]  T. Lyons,et al.  Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo * , 1997, The Journal of Biological Chemistry.

[129]  G. Spiteller,et al.  α-Hydroxyaldehyde Derivatives Arising from Oxidation of Plasmalogens† , 1992 .

[130]  K. Žarković.  4-hydroxynonenal and neurodegenerative diseases. , 2003, Molecular aspects of medicine.

[131]  D. Grant,et al.  Linoleic acid epoxide promotes the maintenance of mitochondrial function and active Na+ transport following hypoxia. , 2004, Toxicology letters.

[132]  S. Hazen.  Myeloperoxidase and plaque vulnerability. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[133]  T. Lyons,et al.  Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. , 1991, Biochemistry.

[134]  J. Heinecke.  Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. , 1999, The Journal of laboratory and clinical medicine.

[135]  S. Wassall,et al.  Docosahexaenoic acid: membrane properties of a unique fatty acid. , 2003, Chemistry and physics of lipids.

[136]  K. Uchida.  Histidine and lysine as targets of oxidative modification , 2003, Amino Acids.

[137]  E. Jeffery,et al.  The relationship between nickel chloride-induced peroxidation and DNA strand breakage in rat liver. , 1992, Toxicology and applied pharmacology.

[138]  D. Straus,et al.  Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression. , 1998, Biochimica et biophysica acta.

[139]  L. Sayre,et al.  Independent Synthesis, Solution Behavior, and Studies on the Mechanism of Formation of a Primary Amine-Derived Fluorophore Representing Cross-linking of Proteins by (E)-4-Hydroxy-2-nonenal , 1999 .

[140]  A. Mazel,et al.  Induction of cell death in arabidopsis by superoxide in combination with salicylic acid or with protein synthesis inhibitors. , 2001, Free radical biology & medicine.

[141]  R. L. Jones,et al.  The identification of an epoxy-hydroxy acid as a product from the incubation of arachidonic acid with washed blood platelets. , 1979, Prostaglandins.

[142]  N. Voelkel,et al.  Leukotoxins and the lung. , 1999, Pulmonary pharmacology & therapeutics.

[143]  E. Stadtman,et al.  Recent advances in the analysis of oxidized proteins , 2003, Amino Acids.

[144]  L. Horrocks,et al.  Neural membrane phospholipids in alzheimer disease , 1995, Neurochemical Research.

[145]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[146]  J. Witztum,et al.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[147]  L. Weber,et al.  Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model , 2003, Critical reviews in toxicology.

[148]  Wei Liu,et al.  4-hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions. , 2003, Molecular aspects of medicine.

[149]  T. Montine,et al.  Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction , 2005, Brain Research.

[150]  M. Alberghina.  Biochemistry of lipids in vascular function. , 2004 .

[151]  H. Imai,et al.  Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. , 2003, Free radical biology & medicine.

[152]  J. Oates,et al.  Ionophores stimulate prostaglandin and thromboxane biosynthesis. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[153]  T. Osawa,et al.  Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. , 1999, The Journal of biological chemistry.

[154]  H. Sies,et al.  Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.

[155]  J. Baynes,et al.  Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.

[156]  V. Calabrese,et al.  Vitamin E and Neurodegenerative Disorders Associated with Oxidative Stress , 2002, Nutritional neuroscience.

[157]  I. Ifrim,et al.  Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. , 1977, Science.

[158]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[159]  G. Spiteller,et al.  Increase of aldehydic compounds derived from plasmalogens in the brain of aged cattle. , 1996, Chemistry and physics of lipids.

[160]  Frank Roels,et al.  Peroxisomal Disorders and Regulation of Genes , 2003, Advances in Experimental Medicine and Biology.

[161]  Ronald J A Wanders,et al.  Functions and biosynthesis of plasmalogens in health and disease. , 2004, Biochimica et biophysica acta.

[162]  A. Scanu,et al.  Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. , 1992, The Journal of biological chemistry.

[163]  T. Vasankari,et al.  Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. , 1999, Free radical biology & medicine.

[164]  G. Spiteller,et al.  Lipid oxidation products in ischemic porcine heart tissue. , 1996, Chemistry and physics of lipids.

[165]  J. Tabet,et al.  Identification of 4-hydroxy-2-nonenal-modified peptides within unfractionated digests using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2004, Analytical chemistry.

[166]  H. Tohgi,et al.  Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease , 1999, Neuroscience Letters.

[167]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[168]  Mohammad Abdollahi,et al.  Pesticides and oxidative stress: a review. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[169]  G. Merényi,et al.  Tyrosine Nitration by Simultaneous Generation of ⋅NO and O⨪2 under Physiological Conditions , 2000, The Journal of Biological Chemistry.

[170]  F. Ausubel,et al.  Programmed cell death in plants: A pathogen-triggered response activated coordinately with multiple defense functions , 1994, Cell.

[171]  J. Trojanowski,et al.  12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. , 2004, The American journal of pathology.

[172]  Y. Yamaguchi,et al.  Self defensive substances in rice plant against rice blast disease , 1983 .

[173]  J. Baynes,et al.  Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. , 1995, Biochemistry.

[174]  S. Avery,et al.  Induction of lipid peroxidation during heavy metal stress in Saccharomyces cerevisiae and influence of plasma membrane fatty acid unsaturation , 1997, Applied and environmental microbiology.

[175]  R. C. Johnson,et al.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[176]  G. Ulsaker,et al.  Gas chromatographic-mass spectrometric identification of four triene monoepoxides of arachidonic acid in human plasma. , 1990, The Analyst.

[177]  T. Montine,et al.  Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[178]  G. Spiteller.  Lipid peroxidation in aging and age-dependent diseases , 2001, Experimental Gerontology.

[179]  H. Vlassara.  Advanced glycation end-products and atherosclerosis. , 1996, Annals of medicine.

[180]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[181]  V. Sridevi,et al.  Heat Shock Induced Lipid Changes and Solute Leakage in Germinating Seeds of Pigeonpea , 2002, Biologia Plantarum.

[182]  J. Falck,et al.  Identification of the 11,14,15- and 11,12,15-Trihydroxyeicosatrienoic Acids as Endothelium-derived Relaxing Factors of Rabbit Aorta* , 1998, The Journal of Biological Chemistry.

[183]  J. Arnaud,et al.  Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis. , 1993, American heart journal.

[184]  J. Baynes,et al.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.

[185]  G. Spiteller,et al.  Oxidation of furan fatty acids by soybean lipoxygenase-1 in the presence of linoleic acid. , 1994, Chemistry and physics of lipids.

[186]  A. Sidhu,et al.  Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation , 2003, Brain Research.

[187]  E. Stadtman,et al.  Oxidation of methionine residues of proteins: biological consequences. , 2003, Antioxidants & redox signaling.

[188]  F. Hayase,et al.  Detection and determination of glyceraldehyde‐derived advanced glycation end product , 2004, BioFactors.

[189]  Evi Kostenis,et al.  A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. , 2004, Pharmacology & therapeutics.

[190]  B. Howard,et al.  Antioxidant Vitamin Supplements and Cardiovascular Disease , 2004, Circulation.

[191]  C. Raetz,et al.  Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation. , 1988, The Journal of biological chemistry.

[192]  H. Kühn,et al.  The role of lipoxygenase-isoforms in atherogenesis. , 2005, Molecular nutrition & food research.

[193]  M. Percival.  Human 5-lipoxygenase contains an essential iron. , 1991, The Journal of biological chemistry.

[194]  B. Becker,et al.  Modeling of risk factors for the degeneration of retinal ganglion cells following ischemia/reperfusion in rats: effects of age, caloric restriction, diabetes, pigmentation, and glaucoma , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[195]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[196]  J. Boyle,et al.  Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. , 2005, Current vascular pharmacology.

[197]  M. Cabrini,et al.  The insidious effect of diatoms on copepod reproduction , 1999, Nature.

[198]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[199]  D. Selkoe,et al.  Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.

[200]  P. Chang,et al.  Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[201]  S. Horiuchi,et al.  Increased production of urea hydrogen peroxide from Maillard reaction and a UHP-Fenton pathway related to glycoxidation damage in chronic renal failure. , 2004, Journal of the American Society of Nephrology : JASN.

[202]  M. Glomb,et al.  Amides Are Novel Protein Modifications Formed by Physiological Sugars* , 2001, The Journal of Biological Chemistry.

[203]  H. Rasmussen,et al.  Regulation of cyclic AMP metabolism in the rat erythrocyte during chronicβ-adrenergic stimulation. Evidence for calmodulin-mediated alteration of membrane-bound phosphodiesterase activity , 1981, The Journal of Membrane Biology.

[204]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[205]  B. Engelmann.  Plasmalogens: targets for oxidants and major lipophilic antioxidants. , 2004, Biochemical Society transactions.

[206]  A. Jenkins,et al.  Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions , 2000, The Journal of Biological Chemistry.

[207]  S. Rapoport,et al.  A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondria , 1975, FEBS letters.

[208]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[209]  Martin J. Mueller,et al.  Formation of isoprostane F(2)-like compounds (phytoprostanes F(1)) from alpha-linolenic acid in plants. , 2000, Free radical biology & medicine.

[210]  T. Ozawa,et al.  Neutrophil microsomes biosynthesize linoleate epoxide (9,10-epoxy-12-octadecenoate), a biological active substance. , 1988, Biochemical and biophysical research communications.

[211]  Spiteller.  Oxidation of Linoleic Acid in Low-Density Lipoprotein: An Important Event in Atherogenesis. , 2000, Angewandte Chemie.

[212]  C. Bailly,et al.  Osmoconditioning reduces physiological and biochemical damage induced by chilling in soybean seeds. , 2001, Physiologia plantarum.

[213]  W. Kern,et al.  Aldehydic lipid peroxidation products derived from linoleic acid. , 2001, Biochimica et biophysica acta.

[214]  L. Lue,et al.  Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism , 2001, Experimental Neurology.

[215]  J. Morrow,et al.  Identification of Extremely Reactive γ-Ketoaldehydes (Isolevuglandins) as Products of the Isoprostane Pathway and Characterization of Their Lysyl Protein Adducts* , 1999, The Journal of Biological Chemistry.

[216]  B. Ames,et al.  Oxidative damage to DNA: relation to species metabolic rate and life span. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[217]  T. Montine,et al.  Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease , 1998, Annals of neurology.

[218]  D. Butterfield,et al.  Elevated glutathione as a therapeutic strategy in Alzheimer's disease , 2002 .

[219]  E. Stadtman,et al.  Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. , 1994, Biochemistry.

[220]  G. Barillari,et al.  Nitrotyrosine in peripheral vascular disease , 2003, Journal of thrombosis and haemostasis : JTH.

[221]  W. Pryor,et al.  Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. , 1990, Free radical biology & medicine.

[222]  J. Valentine,et al.  An Alternative Mechanism of Bicarbonate-mediated Peroxidation by Copper-Zinc Superoxide Dismutase , 2003, Journal of Biological Chemistry.

[223]  G. Bondjers,et al.  Arterial repair and atherosclerosis after mechanical injury , 1971 .

[224]  F. Marks,et al.  Prostaglandins, leukotrienes, and other eicosanoids : from biogenesis to clinical applications , 1999 .

[225]  D. Praticò,et al.  Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. , 2000, The American journal of medicine.

[226]  G. Spiteller,et al.  On the cytotoxity of oxidized phytosterols isolated from photoautotrophic cell cultures of Chenopodium rubrum tested on meal-worms Tenebrio molitor , 1998 .

[227]  K. Fujimoto,et al.  Age-dependent accumulation of phosphatidylcholine hydroperoxide in the brain and liver of the rat , 1993, Lipids.

[228]  E. Sigal,et al.  Identification of a specific methionine in mammalian 15-lipoxygenase which is oxygenated by the enzyme product 13-HPODE: dissociation of sulfoxide formation from self-inactivation. , 1995, Biochemistry.

[229]  V. Preedy,et al.  Oxidized products of cholesterol: toxic effects. , 2005 .

[230]  H. Ukeda,et al.  Spectrophotometric Assay of Superoxide Anion Formed in Maillard Reaction Based on Highly Water-soluble Tetrazolium Salt , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[231]  J. Baynes,et al.  Glycoxidation and lipoxidation in atherogenesis. , 2000, Free radical biology & medicine.

[232]  S. Clarke.  The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors , 2004, Current opinion in lipidology.

[233]  B. Egan,et al.  Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion , 2004, Hypertension.

[234]  K. Feingold,et al.  Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.M200266-JLR200 , 2003, Journal of Lipid Research.

[235]  G. Spiteller,et al.  Enzymatic production of hydroperoxides of unsaturated fatty acids by injury of mammalian cells. , 1996, Chemistry and physics of lipids.

[236]  Munehiro Yoshida,et al.  A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. , 1998, Biomedical chromatography : BMC.

[237]  S. Orrenius,et al.  Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. , 1994, The Journal of biological chemistry.

[238]  P. Kovacic.  Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. , 2005, Medical hypotheses.

[239]  G. Spiteller,et al.  Epoxidation — a consequence of cell damage , 1997 .

[240]  P. Saikku.  Chlamydia pneumoniae and atherosclerosis--an update. , 1997, Scandinavian journal of infectious diseases. Supplementum.

[241]  S. Jimi,et al.  Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody. , 1998, Biochimica et biophysica acta.

[242]  I. Feussner,et al.  Unprecedented lipoxygenase/hydroperoxide lyase pathways in the moss Physcomitrella patens. , 2004, Angewandte Chemie.

[243]  G. Aykaç-toker,et al.  An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women , 2003, Clinical and Experimental Medicine.

[244]  W. Pryor,et al.  Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides , 1976, Lipids.

[245]  5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders. , 2004, Critical reviews in neurobiology.

[246]  H. Gardner.  Oxygen radical chemistry of polyunsaturated fatty acids. , 1989, Free radical biology & medicine.

[247]  P. Libby,et al.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.

[248]  C. Rouzer,et al.  Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. , 1988, The Journal of biological chemistry.

[249]  Donald E Ingber,et al.  Mechanical control of tissue growth: function follows form. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[250]  D. Butterfield,et al.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .

[251]  J. Baynes,et al.  Role of the Maillard Reaction in Aging of Tissue Proteins , 1998, The Journal of Biological Chemistry.

[252]  G. Spiteller.  Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases? , 2003, Medical hypotheses.

[253]  M. Record,et al.  Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. , 1984, Biochimica et biophysica acta.

[254]  S. Arlt,et al.  Increased lipoprotein oxidation in Alzheimer's disease. , 2000, Free radical biology & medicine.

[255]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[256]  K. Beyreuther,et al.  Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.

[257]  D. Silverman,et al.  Exchange of 18O in the reaction of peroxynitrite with CO2 , 2005 .

[258]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[259]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[260]  V. Monnier,et al.  Cross‐Linking of the Extracellular Matrix by the Maillard Reaction in Aging and Diabetes: An Update on “a Puzzle Nearing Resolution” , 2005, Annals of the New York Academy of Sciences.

[261]  M. Beal.  Oxidative Damage in Neurodegenerative Diseases , 1997 .

[262]  G. Perry,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[263]  U. Diczfalusy.  Analysis of cholesterol oxidation products in biological samples. , 2004, Journal of AOAC International.

[264]  R. Ross,et al.  Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .

[265]  G. Spiteller.  The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis. , 2005, Molecular nutrition & food research.

[266]  H. Vainio,et al.  Styrene oxidation to styrene oxide coupled with arachidonic acid oxidation by soybean lipoxygenase. , 1983, Toxicology letters.

[267]  K. Messmer,et al.  Early inflammatory response to asbestos exposure in rat and hamster lungs: role of inducible nitric oxide synthase. , 2002, Toxicology and applied pharmacology.

[268]  Á. Simonyi,et al.  Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. , 2004, Journal of lipid research.

[269]  W. Kern,et al.  Synthesis and properties of natural occurring α-hydroxyaldehydes , 1996 .

[270]  L. See,et al.  Increase of lipid peroxidation by cisplatin in WI38 cells but not in SV40‐transformed WI38 cells , 2003, Journal of biochemical and molecular toxicology.

[271]  Y. Hellsten,et al.  Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. , 2003, Free radical biology & medicine.

[272]  V. Monnier,et al.  Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*) , 1995, The Journal of Biological Chemistry.

[273]  J. Beneytout,et al.  trans,trans-2,4-decadienal: cytotoxicity and effect on glutathione level in human erythroleukemia (HEL) cells. , 1996, Cancer letters.

[274]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[275]  E. Blée,et al.  Biosynthesis of phytooxylipins: the Peroxygenase pathway , 1998 .

[276]  V. Monnier,et al.  Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. , 1991, The Journal of biological chemistry.

[277]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[278]  I. Kullo,et al.  Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[279]  S. Arlt,et al.  Use of vitamin C and E in the treatment of Alzheimer's disease , 2002 .

[280]  Alexander A Spector,et al.  Emergent patterns of growth controlled by multicellular form and mechanics. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[281]  M. Zagorski,et al.  Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution , 1984 .

[282]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[283]  M. Lebl,et al.  Peptides: The Wave of the Future , 2001, American Peptide Symposia.

[284]  B. Wolozin,et al.  The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. , 2006, CNS drug reviews.

[285]  E. Wills.  Mechanisms of lipid peroxide formation in animal tissues. , 1966, The Biochemical journal.

[286]  A. Nègre-Salvayre,et al.  Impairment of the cytotoxic and oxidative activities of 7 beta-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. , 2003, Biochemical and biophysical research communications.

[287]  J. Bohl,et al.  Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques , 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[288]  S. Hazen,et al.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. , 2003, JAMA.

[289]  D. Bernlohr,et al.  Covalent Modification of Epithelial Fatty Acid-binding Protein by 4-Hydroxynonenal in Vitro and in Vivo , 2002, The Journal of Biological Chemistry.

[290]  A. Benedetti,et al.  Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids. Identification of 4,5-dihydroxydecenal. , 1984, Biochimica et biophysica acta.

[291]  J. Baynes,et al.  Pathways of formation of glycoxidation products during glycation of collagen. , 1995, Biochemistry.

[292]  G. Holmquist,et al.  Mapping of peroxyl radical induced damage on genomic DNA. , 1999, Biochemistry.

[293]  N. Porter.  Mechanisms for the autoxidation of polyunsaturated lipids , 1986 .

[294]  P. Reaven,et al.  Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. , 2002, Journal of lipid research.

[295]  A. Mally,et al.  Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats. , 2005, Free radical biology & medicine.

[296]  A. Loidl-Stahlhofen,et al.  α-Hydroxyaldehydes, products of lipid peroxidation , 1994 .

[297]  P. Lantos,et al.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[298]  J. Cravedi,et al.  Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. , 2003, Molecular aspects of medicine.

[299]  W. Frishman,et al.  Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. , 1997, Progress in cardiovascular diseases.

[300]  I. Rahman.  Smoking-Induced Inflammation, Injury and Disease: Molecular Mechanisms , 2004 .

[301]  P. Riederer,et al.  Dramatic increase of α-hydroxyaldehydes derived from plasmalogens in the aged human brain , 1997 .

[302]  D. Grant,et al.  Defining mechanisms of toxicity for linoleic acid monoepoxides and diols in Sf-21 cells. , 2001, Chemical research in toxicology.

[303]  J. Joseph,et al.  Nitration of γ-tocopherol and oxidation of α-tocopherol by copper-zinc superoxide dismutase/H2O2/NO2−: Role of nitrogen dioxide free radical , 1998 .

[304]  V. A. Folcik,et al.  Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. , 1995, The Journal of clinical investigation.